BrainCool AB (publ) Receives US FDA De Novo Clearance for the Cooral® System for Reduction of Oral Mucositis
Annapolis, Maryland —November 1st, 2022—BrainCool Inc a subsidiary of the Swedish medical device innovator BrainCool AB (publ), announced the launch of Cooral® System which has been approved though a De Novo clearance by the U.S. Food and Drug Administration (FDA). The market clearance paves the way for reduction of one of the most severe side-effects [...]